Advances in the study of Rho kinase and its inhibitors

Yaoxue Xuebao

Volumn 42, Issue 10, 2007, Pages 1013-1022

  Duan, Wei Gang ^a   Yuan, Sheng Tao ^a   Liao, Hong ^a   Yan, Ming ^a   Zhang, Lu Yong ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Drug screening; Inhibitor; Rho associated kinase

Indexed keywords

1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE; 4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; AMIDE; ANTIHYPERTENSIVE AGENT; DRUG DERIVATIVE; FASUDIL; PYRIDINE DERIVATIVE; RHO KINASE; VASODILATOR AGENT;

CARDIOVASCULAR DISEASE; CHEMISTRY; DRUG ANTAGONISM; HUMAN; METABOLISM; REVIEW; SIGNAL TRANSDUCTION; SUBARACHNOID HEMORRHAGE;

1-(5-ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE; AMIDES; ANTIHYPERTENSIVE AGENTS; CARDIOVASCULAR DISEASES; HUMANS; PYRIDINES; RHO-ASSOCIATED KINASES; SIGNAL TRANSDUCTION; SUBARACHNOID HEMORRHAGE; VASODILATOR AGENTS;

EID: 42149117843     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (68)

1. Mueller BK, Mack H, Teusch N. Rho kinase, a promising drug target for neurological disorders [J]. Nat Rev Drug Discov, 2005,4:387-398.
2. Matsui T, Amano M, Yamamoto T, et al. Rho-associated kinase, a novel serine / threonine kinase, as a putative target for small GTP binding protein Rho [J]. Embo J, 1996,15:2208-2216.
3. Riento K , Ridley AJ. Rocks : multifunctional kinases in cell behaviour [J]. Nat Rev Mol Cell Biol, 2003,4:446-456.
4. Yamaguchi H, Miwa Y, Kasa M, et al. Structural basis for induced-fit binding of Rho-kinase to the inhibitor Y27632 [J]. J Biochem (Tokyo), 2006,140:305-311.
5. Takami A, Iwakubo M, Okada Y, et al. Design and synthesis of Rho kinase inhibitors (I) [J]. Bioorg Med Chem, 2004,12:2115-2137.
6. Breitenlechner C, Gassel M, Engh R, et al. Structural insights into AGC kinase inhibition [J]. Oncol Res, 2004,14:267-278.
7. Tanaka T, Nishimura D, Wu RC, et al. Nuclear Rho kinase, ROCK2, targets p300 acetyltransferase [J]. J Biol Chem, 2006,281:15320-15329.
8. Ishizaki T. Rho-mediated signal transduction and its physiological roles [J]. Nippon Yakurigaku Zasshi, 2003,121:153-162.
9. Amano M, Fukata Y, Kaibuchi K. Regulation and functions of Rho-associated kinase [J]. Exp Cell Res, 2000,261:44-51.
10. Riento K, Guasch RM, Garg R, et al. RhoE binds to ROCK I and inhibits downstream signaling [J]. Mol Cell Biol, 2003,23:4219-4229.
11. Chang J, Xie M, Shah VR, et al. Activation of Rho-associated coiled-coil protein kinase 1 (ROCK-1) by caspase-3 cleavage plays an essential role in cardiac myocyte apoptosis [J]. Proc Natl Acad Sci USA, 2006,103:14495-14500.
12. Sebbagh M, Hamelin J, Bertoglio J, et al. Direct cleavage of ROCK II by granzyme B induces target cell membrane blebbing in a caspase-independent manner [J]. J Exp Med, 2005,201:465-471.
13. Busca R, Bertolotto C, Abbe P, et al. Inhibition of Rho is required for cAMP-induced melanoma cell differentiation [J]. Mol Biol Cell, 1998,9:1367-1378.
14. Fukata Y, Oshiro N, Kinoshita N, et al. Phosphorylation of adducin by Rho-kinase plays a crucial role in cell motility [J]. J Cell Biol, 1999,145:347-361.
15. Kaneko T, Amano M, Maeda A, et al. Identification of calponin as a novel substrate of Rho-kinase [J]. Biochem Biophys Res Commun, 2000,273:110-116.
16. Arimura N, Inagaki N, Chihara K, et al. Phosphorylation of collapsin response mediator protein-2 by Rho-kinase. Evidence for two separate signaling pathways for growth cone collapse [J]. J Biol Chem, 2000,275:23973-23980.
17. Koyama M, Ito M, Feng J, et al. Phosphorylation of CPI-17, an inhibitory phosphoprotein of smooth muscle myosin phosphatase, by Rho-kinase [J]. FEBS Lett, 2000,475:197-200.
18. Inada H, Goto H, Tanabe K, et al. Rho-associated kinase phosphorylates desmin, the myogenic intermediate filament protein, at unique amino-terminal sites [J]. Biochem Biophys Res Commun, 1998,253:21-25.
19. Kaneko T, Maeda A, Takefuji M, et al. Rho mediates endocytosis of epidermal growth factor receptor through phosphorylation of endophilin Al by Rho-kinase [J]. Genes Cells, 2005,10:973-987.
20. Torsoni AS, Marin TM, Velloso LA, et al. RhoA/ROCK signaling is critical to FAK activation by cyclic stretch in cardiac myocytes [J]. Am J Physiol Heart Circ Physiol, 2005,289:H1488-1496.
21. Jeon S, Kim S, Park JB, et al. RhoA and Rho kinase-dependent phosphorylation of moesin at Thr-558 in hippocampal neuronal cells by glutamate [J]. J Biol Chem, 2002,277:16576-16584.
22. Kosako H, Amano M, Yanagida M, et al. Phosphorylation of glial fibrillary acidic protein at the same sites by cleavage furrow kinase and Rho-associated kinase [J]. J Biol Chem, 1997,272:10333-10336.
23. Anwar KN, Fazal F, Malik AB, et al. RhoA/Rho-associated kinase pathway selectively regulates thrombin-induced intercellular adhesion molecule-1 expression in endothelial cells via activation of I kappa B kinase beta and phosphorylation of RelA/p65 [J]. J Immunol, 2004,173:6965-6972.
24. Ohashi K, Nagata K, Maekawa M, et al. Rho-associated kinase ROCK activates LIM-kinase 1 by phosphorylation at threonine 508 within the activation loop [J]. J Biol Chem, 2000,275:3577-3582.
25. Togashi H, Nagata K, Takagishi M, et al. Functions of a Rho-specific guanine nucleotide exchange factor in neurite retraction. Possible role of a proline-rich motif of KIAA0380 in localization [J]. J Biol Chem, 2000,275:29570-29578.
26. Sumi T, Matsumoto K, Nakamura T. Specific activation of LIM kinase 2 via phosphorylation of threonine 505 by ROCK, a Rho-dependent protein kinase [J]. J Biol Chem, 2001,276:670-676.
27. Amano M, Kaneko T, Maeda A, et al. Identification of Tau and MAP2 as novel substrates of Rho-kinase and myosin phosphatase [J]. J Neurochem, 2003,87:780-790.
28. Amano M, Ito M, Kimura K, et al. Phosphorylation and activation of myosin by Rho-associated kinase ( Rho-kinase) [J]. J Biol Chem, 1996,271:20246-20249.
29. Watanabe Y, Faraci FM, Heistad DD. Activation of Rhoassociated kinase during augmented contraction of the basilar artery to serotonin after subarachnoid hemorrhage [J]. Am J Physiol Heart Circ Physiol, 2005,288:H2653-2658.
30. Birukova AA, Smurova K, Birukov KG, et al. Role of Rho GTPases in thrombin-induced lung vascular endothelial cells barrier dysfunction [J]. Microvasc Res, 2004,67:64-77.
31. 2+ sensitization: Rho-associated kinase-mediated phosphorylation of MYPTl at Thr-855, but not Thr-697 [J]. Biochem J, 2005,389:763-774.
32. Tominaga T, Ishizaki T, Narumiya S, et al. p160ROCK mediates RhoA activation of Na-H exchange [J]. Embo J, 1998,17:4712-4722.
33. + exchanger NHE3. Role of myosin light chain phosphorylation [J]. J Biol Chem, 2000,275:28599-28606.
34. Hashimoto R, Nakamura Y, Goto H, et al. Domain- and site-specific phosphorylation of bovine NF-L by Rho-associated kinase [J]. Biochem Biophys Res Commun, 1998,245:407-411.
35. Hirase T, Kawashima S, Wong EY, et al. Regulation of tight junction permeability and occludin phosphorylation by Rhoa-p160ROCK-dependent and - independent mechanisms [J]. J Biol Chem, 2001,276:10423-10431.
36. Yang SA, Carpenter CL, Abrams CS. Rho and Rhokinase mediate thrombin-induced phosphatidylinositol 4-phosphate 5-kinase trafficking in platelets [J]. J Biol Chem, 2004,279:42331-42336.
37. Yamaguchi Y, Katoh H, Yasui H, et al. RhoA inhibits the nerve growth factor-induced Rac1 activation through Rho-associated kinase-dependent pathway [J]. J Biol Chem, 2001,276:18977-18983.
38. Turner MS, Fen L, Trauger JW, et al. Characterization and purification of truncated human Rho-kinase II expressed in Sf-21 cells [J]. Arch Biochem Biophys, 2002,405:13-20.
39. Inada H, Togashi H, Nakamura Y, et al. Balance between activities of Rho kinase and type 1 protein phosphatase modulates turnover of phosphorylation and dynamics of desmin/vimentin filaments [J]. J Biol Chem, 1999,274:34932-34939.
40. Goto H, Kosako H, Tanabe K, et al. Phosphorylation of vimentin by Rho-associated kinase at a unique amino-terminal site that is specifically phosphorylated during cytokinesis [J]. J Biol Chem, 1998,273:11728-11736.
41. Bao W, Hu E, Tao L, et al. Inhibition of Rho-kinase protects the heart against ischemia/reperfusion injury [J]. Cardiovasc Res, 2004,61:548-558.
42. Chitaley K, Webb RC , Mills TM. The ups and downs of Rho-kinase and penile erection: upstream regulators and downstream substrates of Rho-kinase and their potential role in the erectile response [J]. Int J Impot Res, 2003,15:105-109.
43. Fournier AE, Takizawa BT, Strittmatter SM. Rho kinase inhibition enhances axonal regeneration in the injured CNS [J]. J Neurosci, 2003,23:1416-1423.
44. Honing H, van den Berg TK, van der Pol SM, et al. RhoA activation promotes transendothelial migration of monocytes via ROCK [J]. J Leukocyte Biol, 2004,75:523-528.
45. Hendriks JJ, Alblas J, van der Pol SM, et al. Flavonoids influence monocytic GTPase activity and are protective in experimental allergic encephalitis [J]. J Exp Med, 2004,200:1667-1672.
46. Toshima Y, Satoh S, Ikegaki I, et al. A new model of cerebral microthrombosis in rats and the neuroprotective effect of a Rho-kinase inhibitor [J]. Stroke, 2000,31:2245-2250.
47. Kitaoka Y, Kitaoka Y, Kumai T, et al. Involvement of RhoA and possible neuroprotective effect of fasudil, a Rho kinase inhibitor, in NMDA-induced neurotoxicity in the rat retina [J]. Brain Res, 2004,1018:111-118.
48. Tatsumi S, Mabuchi T, Katano T, et al. Involvement of Rho-kinase in inflammatory and neuropathic pain through phosphorylation of myristoylated alanine-rich C-kinase substrate ( MARCKS) [J]. Neuroscience, 2005,131:491-498.
49. Murata T, Arii S, Nakamura T, et al. Inhibitory effect of Y-27632, a ROCK inhibitor, on progression of rat liver fibrosis in association with inactivation of hepatic stellate cells [J]. J Hepatol, 2001,35:474-481.
50. Shimizu Y, Dobashi K, Iizuka K, et al. Contribution of small GTPase Rho and its target protein rock in a murine model of lung fibrosis [J]. Am J Respir Crit Care Med, 2001,163:210-217.
51. Nagatoya K, Moriyama T, Kawada N, et al. Y-27632 prevents tubulointerstitial fibrosis in mouse kidneys with unilateral ureteral obstruction [J]. Kidney Int, 2002,61:1684-1695.
52. Nakajima M, Hayashi K, Egi Y, et al. Effect of Wf-536, a novel ROCK inhibitor, against metastasis of B16 melanoma [J]. Cancer Chemother Pharmacol, 2003,52:319-324.
53. Uehata M, Ishizaki T, Satoh H, et al. Calcium sensitization of smooth muscle mediated by a Rhoassociated protein kinase in hypertension [J]. Nature, 1997,389:990-994.
54. Iwakubo M, Takami A, Okada Y, et al. Design and synthesis of Rho kinase inhibitors (III) [J]. Bioorg Med Chem, 2007,15:1022-1033.
55. Iwakubo M, Takami A, Okada Y, et al. Design and synthesis of Rho kinase inhibitors (II) [J]. Bioorg Med Chem, 2007,15:350-364.
56. Tamura M, Nakao H, Yoshizaki H, et al. Development of specific Rho-kinase inhibitors and their clinical application [J]. Biochim Biophys Acta, 2005,1754:245-252.
57. Gingras K, Avedissian H, Thouin E, et al. Synthesis and evaluation of 4-(1-aminoalkyl)-N-(4-pyridyl) cyclohexanecarboxamides as Rho kinase inhibitors and neurite outgrowth promoters [J]. Bioorg Med Chem Lett, 2004,14:4931-4934.
58. Yarrow JC, Totsukawa G, Charras GT, et al. Screening for cell migration inhibitors via automated microscopy reveals a Rho-kinase inhibitor [J]. Chem Biol, 2005,12:385-395.
59. Sebbagh M, Renvoize C, Hamelin J, et al. Caspase-3-mediated cleavage of ROCK I induces MLC phosphorylation and apoptotic membrane blebbing [J]. Nat Cell Biol, 2001,3:346-352.
60. Davies SP, Reddy H, Caivano M, et al. Specificity and mechanism of action of some commonly used protein kinase inhibitors [J]. Biochem J, 2000,351:95-105.
61. Ishizaki T, Uehata M, Tamechika I, et al. Pharmacological properties of Y-27632, a specific inhibitor of Rho-associated kinases [J]. Mol Pharmacol, 2000,57:976-983.
62. Sasaki Y, Suzuki M, Hidaka H. The novel and specific Rho-kinase inhibitor (S)-(+)-2-methyl-1-[(4-methyl-5-isoquinoline) sulfonyl] -homopiperazine as a probing molecule for Rho-kinase-involved pathway [J]. Pharmacol Ther, 2002,93:225-232.
63. Ikenoya M, Hidaka H, Hosoya T, et al. Inhibition of Rho-kinase-induced myristoylated alanine-rich C kinase substrate (MARCKS) phosphorylation in human neuronal cells by H-1152, a novel and specific Rho-kinase inhibitor [J]. J Neurochem, 2002,81:9-16.
64. Duan W, Sun L, Liu J, et al. Establishment and application of a high throughput model for Rho kinase inhibitors screening based on fluorescence polarization [J]. Biol Pharm Bull, 2006,29:1138-1142.
65. Duan W, Wang S, Chen M, et al. Harvest active recombinant Rho kinase from Escherichia coli [J]. Biol Pharm Bull, 2006,29:38-42.
66. Hirooka Y, Shimokawa H. Therapeutic potential of Rhokinase inhibitors in cardiovascular diseases [J]. Am J Cardiovasc Drugs, 2005,5:31-39.
67. Ishida T, Takanashi Y, Doi H, et al. Encapsulation of an antivasospastic drug, fasudil, into liposomes, and in vitro stability of the fasudil-loaded liposomes [J]. Int J Pharm, 2002,232:59-67.
68. Zhou Y, Su Y, Li B, et al. Nonsteroidal anti-inflammatory drugs can lower amyloidogenic Abeta42 by inhibiting Rho [J]. Science, 2003,302:1215-1217.